Current Research Studies

SC-N145, Targeted Therapy to Increase RAI Uptake in Patients with Metastatic Differentiated Thyroid Cancer

SC-N145, Targeted Therapy in Metastatic PTC

Condition(s): Newly diagnosed, Recurrent and/or Refractory, Solid Tumor, Thyroid Cancer
Phase: N/A
Clinicaltrials.gov ID: NCT05024929

What is the goal of the study?

The goal of this study is to learn more about how targeted therapy affects the radioactive iodine (RAI) absorption by your cancer.

Who can participate in the study?

This study may be a good fit for children and young adults who: • Have Differentiated Thyroid Cancer (DTC) that has spread to the lungs • Are planning to be treated with a targeted therapy

Study Team:

PI (Study Doctor): Tyler Ketterl
Study Team Member: HemOnc CRAs, [email protected]